Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 187
Selected: 0
NCT IDTitle
NCT00005027Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
NCT00003220Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
NCT00014573Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
NCT01270880Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
NCT00078923Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
NCT03091257A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT04055649ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
NCT00288028Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
NCT00503841Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
NCT00003250Fenretinide in Treating Patients With Solid Tumors
NCT00011973Chemotherapy in Treating Patients With Advanced Kidney Cancer
NCT03454529The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer
NCT06908629Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
NCT00903214Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00003936Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
NCT03406858Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
NCT05222438Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant
NCT00717535Studying Umbilical Cord Blood From African-American Donors
NCT07222306Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study
NCT01022138Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer
NCT00028548XK469 in Treating Patients With Advanced Solid Tumors
NCT00248482Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00906503Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules
NCT00002907Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
NCT00897910Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
NCT01813370A Registry for Patients Treated on the Clinical Trial TAX 3503
NCT00002585Pyrazoloacridine in Treating Women With Metastatic Breast Cancer
NCT00459121Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
NCT07218432A Study of the TheraBionic P1 Device in Breast Cancer
NCT03453489AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
NCT01612910Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
NCT00002923KRN5500 in Treating Patients With Metastatic Solid Tumors
NCT01643603Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
NCT06576115Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
NCT01420874Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
NCT02178163Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT01116232Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
NCT02819024Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography
NCT05325281CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
NCT03750981C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)
NCT04266522Medical Physics Direct Patient Care for the Improvement of Patient Understanding of Care
NCT03147885Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
NCT00003626Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
NCT00521261Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT03719677Reducing Metabolic Syndrome Among Breast Cancer Survivors
NCT00248560Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
NCT02568449Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
NCT05025748Ask Questions (ASQ):Implementation of a Communication Intervention
NCT06501040Increasing Knowledge and Interest in Cancer Clinical Trials
NCT02207010A Phase 0 Study of AZD1775 in Recurrent GBM Patients